216 filings
Page 3 of 11
8-K
pgg54 l3u
10 Jun 22
Departure of Directors or Certain Officers
4:15pm
8-K
2apsry c0kwm
3 Jun 22
Regulation FD Disclosure
8:01am
8-K
32imib2yqt 6q24o0
26 May 22
Entry into a Material Definitive Agreement
8:04am
8-K
oymn2yzv
28 Apr 22
Novocure Reports First Quarter 2022 Financial Results
7:04am
DEFA14A
895w apwtl
25 Apr 22
Additional proxy soliciting materials
4:16pm
8-K
vh3bowfz8z1xe3xb4zf
13 Apr 22
Departure of Directors or Certain Officers
4:06pm
8-K
s02fz3vvx
7 Apr 22
Other Events
4:07pm
8-K
wtzz8va891wdtb6if
23 Mar 22
Novocure Announces Favorable Recommendation to Continue the Phase 3 Pivotal INNOVATE-3 Study of Tumor Treating Fields in Ovarian Cancer
8:01am
S-8
v37p7zsybgiasf wcl2d
24 Feb 22
Registration of securities for employees
4:03pm
8-K
xt6fz4p 8q8kpce7y
24 Feb 22
Novocure Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company Update
7:00am
8-K
utam4wfcn9e1
10 Jan 22
Novocure Announces Preliminary Full Year and Fourth Quarter 2021 Net Revenues and Provides Company Update
7:05am
8-K
05ad2r105q4lgvnmwhc
30 Dec 21
Other Events
4:05pm
8-K
ugmy0f tzkxt8k6z
7 Dec 21
Novocure Signs Agreement to Acquire and Construct Building in Downtown Portsmouth, New Hampshire
4:01pm
8-K
hf1ttmk3
28 Oct 21
Novocure Reports Third Quarter 2021 Financial Results and Provides Company Update
6:37am